Ely Benaim - 03 Aug 2022 Form 4 Insider Report for NovoCure Ltd (NVCR)

Role
Chief Medical Officer
Signature
/s/ Steven Robbins Attorney in Fact for Ely Benaim
Issuer symbol
NVCR
Transactions as of
03 Aug 2022
Net transactions value
-$439,328
Form type
4
Filing time
04 Aug 2022, 16:32:39 UTC
Previous filing
03 Aug 2022
Next filing
10 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCR Ordinary Shares Sale $40,024 -563 -1.6% $71.09 34,068 03 Aug 2022 Direct F1
transaction NVCR Ordinary Shares Sale $399,304 -5,396 -16% $74.00 28,672 03 Aug 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Dr. Benaim.